What is the recommended dosing for propranolol (beta blocker) in individuals with severe autism spectrum disorder (ASD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Dosing for Severe Autism Spectrum Disorder

For individuals with severe autism spectrum disorder (ASD), propranolol should be dosed at 0.5-1 mg/kg/day initially, with a target maintenance dose of 1-3 mg/kg/day divided into 2-3 daily doses, based on symptom response and tolerability. 1

Dosing Algorithm

Initial Dosing

  • Starting dose: 0.5-1 mg/kg/day divided into 2-3 doses 1
  • For patients with comorbidities or risk factors for hypoglycemia, start at the lower end (0.5 mg/kg/day)
  • Use propranolol oral solution (5 mg/5 mL) for precise dosing, especially in children

Dose Titration

  • Increase dose gradually at minimum intervals of 24 hours 1
  • Monitor for clinical response and side effects
  • Titrate to target dose of 1-3 mg/kg/day based on symptom control
  • Maximum dose for non-responders: 3 mg/kg/day 1

Target Symptoms and Dosing Considerations

  • For hyperactivity: 0.5-1 mg/kg/day has shown efficacy 1
  • For self-injurious behavior: 0.5-1 mg/kg/day 1
  • For severe challenging behaviors: Higher doses (120-960 mg/day, mean 462 mg) have been used in clinical practice 2

Monitoring Parameters

Before Starting Treatment

  • Cardiovascular and respiratory examination (auscultation, peripheral pulses) 1
  • Baseline heart rate and blood pressure
  • Consider ECG in patients with cardiac risk factors

During Treatment

  • Heart rate and blood pressure at follow-up visits
  • Monitor for signs of hypoglycemia (especially in at-risk patients)
  • Assess for clinical response using standardized measures when possible
  • Follow-up every 2-3 months for stable patients 1

Evidence for Efficacy

Propranolol has demonstrated efficacy for several target symptoms in ASD:

  • Hyperactivity: Significant reduction in hyperactivity with doses of 0.5-1 mg/kg/day 1
  • Self-injurious behavior: Positive trend for improvement 1
  • Conversational reciprocity: Improved social communication with single-dose challenges 3
  • Challenging behaviors: 85% of patients showed improvement on Clinical Global Impression scale with higher doses in a retrospective analysis 2
  • Anxiety: Recent RCT showed benefit for anxiety symptoms at 12 weeks (odds ratio = 2.58) 4

Common Side Effects

  • Transient sedation 1
  • Decreased heart rate and blood pressure
  • Potential for increased aggression and stereotypy in some patients 1
  • Hypoglycemia (particularly in at-risk individuals)

Clinical Pearls

  • Propranolol can be safely discontinued abruptly rather than requiring gradual tapering 1
  • Consider as an add-on to existing medications for challenging behaviors 2
  • For severe challenging behaviors, higher doses (>120 mg/day) may be required, but should be administered under close clinical supervision 2
  • Recent evidence suggests propranolol may be particularly beneficial for anxiety symptoms in ASD 4
  • Low-dose propranolol (0.3 mg/kg/day) has shown efficacy for hypersexual behaviors in adolescents with ASD 5

Contraindications

  • Hypoglycemic episodes (recent or ongoing)
  • Second or third-degree heart block
  • Hypersensitivity to propranolol
  • Blood pressure or heart rate outside normal range for age (relative contraindication; consider specialist consultation) 1

Propranolol represents a promising pharmacological option for managing specific symptoms in severe ASD, particularly challenging behaviors, hyperactivity, and anxiety. While not FDA-approved specifically for ASD, the evidence supports its use as a targeted intervention for specific symptoms when prescribed and monitored appropriately.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.